TrialAmerican journal of hematology2025

A Phase 2 Trial of CPX-351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia.

Tapan M Kadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.